🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Eosinophilic Gastritis

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages NCT02523118n/a19 sites📍 Phoenix📍 Rogers📍 San Diego Children's Hospital Medical Center, Cincinnati Natural History of Eosinophilic Esophagitis in Adult and Pediatric Population NCT07614633n/a2 sites📍 Pavia📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Natural History and Genetics of Food Allergy and Related Conditions NCT02504853n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE). NCT05608681Phase 1, Phase 223 sites📍 Sydney📍 Brisbane📍 Brisbane Eupraxia Pharmaceuticals Inc. · Tests: EP-104GI, Matching vehicle control Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Population With Eosinophilic Esophagitis NCT06972147n/a2 sites📍 Angers📍 Lille University Hospital, Angers Prospective Registry of EoSinophilic esOphagitis NCT06443346n/a1 site📍 Milan IRCCS San Raffaele · Tests: Eosinophilic Esophagitis A Registry for the Food Allergy Community NCT04653324n/a1 site📍 McLean Food Allergy Research & Education Study of Gastric Motility in Eosinophilic Gastritis NCT05229432n/a3 sites📍 Chicago📍 Bethesda📍 Salt Lake City Children's Hospital Medical Center, Cincinnati Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Dupilumab Therapy for EGIDs NCT07257835n/a1 site📍 Shanghai Children's Hospital of Fudan University · Tests: Dupilumab - Standard Dose, subcutaneous injection EDN and Eosinophilic Esophagitis NCT06387030NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Blood sampling, Esophageal biopsies, Unstimulated saliva sampling, Urine sampling, Stool sampling Elimination Diet Strategies and Histologic Remission in Children With Eosinophilic Gastrointestinal Disorders NCT07779772n/a1 site📍 Adana Cukurova University · Tests: Elimination Diet Tolerability of Goat Milk Protein in Eosinophilic Esophagitis Patients With Cow Milk Protein Trigger NCT05180578NA1 site📍 Jerusalem Shaare Zedek Medical Center · Tests: Goat milk diet An Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis. NCT05730933NA1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Intervention Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE) NCT06665971Phase 41 site📍 La Jolla University of California, San Diego · Tests: Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT] Zemaira Eosinophilic Esophagitis Pilot Study NCT05485155Phase 22 sites📍 Bethesda📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Alpha-proteinase inhibitor Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy NCT06389994n/a1 site📍 Philadelphia Children's Hospital of Philadelphia · Tests: Esophageal String Test Characteristics and Inflammatory Markers in Children With Eosinophilic Esophagitis (EoE) NCT03980886n/a1 site📍 San Diego University of California, San Diego Institutional Registry of Rare Diseases NCT06573723n/a1 site📍 Buenos Aires Hospital Italiano de Buenos Aires Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study NCT03312686n/a2 sites📍 Indianapolis📍 Indianapolis Indiana University · Tests: endoflip A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis NCT07588568Phase 22 sites📍 Chapel Hill📍 Durham University of North Carolina, Chapel Hill · Tests: Upadacitinib 30mg Dose, Upadacitinib Matching Placebo A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis NCT07112378Phase 313 sites📍 Phoenix📍 San Francisco📍 Aurora Regeneron Pharmaceuticals · Tests: dupilumab A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany NCT06695897n/a15 sites📍 Aschaffenburg📍 Augsburg📍 Dachau Sanofi · Tests: Dupilumab The Potential Role of Compounds Derived From Ultra-processed Foods in Pathogenesis of Eosinophilic Esophagitis NCT06093204n/a2 sites📍 Naples📍 Naples Federico II University · Tests: Dietary evaluation Eosinophilic Esophagitis: Towards Improved Management NCT06991881n/a2 sites📍 Bergen📍 Oslo Oslo University Hospital · Tests: Biobank sampling for new biomarkers Pediatric Eosinophilic Esophagitis (pedEoE): Effect of Allergen Heat Denaturation on EoE Remission: a Pilot Trial NCT06381219NA1 site📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: Implementation of cow's milk in decreasingly heated forms, Implementation of hen's egg in decreasingly heated… Utility of Mucosal Impedance Device in Chronic Esophageal Disorders: NCT07227506n/a1 site📍 Milwaukee Medical College of Wisconsin · Tests: MuVI Esophageal mucosal impedance testing Eosinophilic Gastrointestinal Disorders Registry NCT05199532n/a1 site📍 Chicago Ann & Robert H Lurie Children's Hospital of Chicago Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE NCT06705387Phase 21 site📍 Aurora University of Colorado, Denver · Tests: Dupilumab, Fluticasone Indiana University Gastrointestinal Motility Diagnosis Registry NCT04506593n/a1 site📍 Indianapolis Indiana University · Tests: no intervention
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy